Gilead Files Viread sNDA For Chronic Hepatitis B
New marketing application for the HIV therapy went to FDA Oct. 10, firm tells “The Pink Sheet” DAILY.
New marketing application for the HIV therapy went to FDA Oct. 10, firm tells “The Pink Sheet” DAILY.